Javascript must be enabled to continue!
Structure-based virtual screening identifies small molecule inhibitors of O-fucosyltransferase SPINDLY
View through CrossRef
Abstract
Protein O-glycosylation is a nutrient-signaling mechanism that plays essential roles in maintaining cellular homeostasis across different species. In plants, SPINDLY (SPY) and SECRET AGENT (SEC) catalyze posttranslational modifications of hundreds of intracellular proteins by O-fucose and O-linked N-acetylglucosamine, respectively. SPY and SEC play overlapping roles in cellular regulation and loss of both SPY and SEC causes embryo lethality in Arabidopsis. Using structure-based virtual screening of chemical libraries followed by
in vitro
and
in planta
assays, we identified a
S
PY
O
-
f
ucosyltransferase
i
nhibitor (SOFTI). Computational analyses predicted that SOFTI binds to the GDP-fucose-binding pocket of SPY and competitively inhibits GDP-fucose binding.
In vitro
assays confirmed that SOFTI interacts with SPY and inhibits its O-fucosyltransferase activity. Docking analysis identified additional SOFTI analogs that showed stronger inhibitory activities. SOFTI treatment of Arabidopsis seedlings decreased protein O-fucosylation and caused phenotypes similar to the
spy
mutants, including early seed germination, increased root hair density, and defect in sugar-dependent growth. By contrast, SOFTI had no visible effect on the
spy
mutant. Similarly, SOFTI inhibited sugar-dependent growth of tomato seedlings. These results demonstrate that SOFTI is a specific SPY O-fucosyltransferase inhibitor and a useful chemical tool for functional studies of O-fucosylation and potentially for agricultural management.
Title: Structure-based virtual screening identifies small molecule inhibitors of O-fucosyltransferase SPINDLY
Description:
Abstract
Protein O-glycosylation is a nutrient-signaling mechanism that plays essential roles in maintaining cellular homeostasis across different species.
In plants, SPINDLY (SPY) and SECRET AGENT (SEC) catalyze posttranslational modifications of hundreds of intracellular proteins by O-fucose and O-linked N-acetylglucosamine, respectively.
SPY and SEC play overlapping roles in cellular regulation and loss of both SPY and SEC causes embryo lethality in Arabidopsis.
Using structure-based virtual screening of chemical libraries followed by
in vitro
and
in planta
assays, we identified a
S
PY
O
-
f
ucosyltransferase
i
nhibitor (SOFTI).
Computational analyses predicted that SOFTI binds to the GDP-fucose-binding pocket of SPY and competitively inhibits GDP-fucose binding.
In vitro
assays confirmed that SOFTI interacts with SPY and inhibits its O-fucosyltransferase activity.
Docking analysis identified additional SOFTI analogs that showed stronger inhibitory activities.
SOFTI treatment of Arabidopsis seedlings decreased protein O-fucosylation and caused phenotypes similar to the
spy
mutants, including early seed germination, increased root hair density, and defect in sugar-dependent growth.
By contrast, SOFTI had no visible effect on the
spy
mutant.
Similarly, SOFTI inhibited sugar-dependent growth of tomato seedlings.
These results demonstrate that SOFTI is a specific SPY O-fucosyltransferase inhibitor and a useful chemical tool for functional studies of O-fucosylation and potentially for agricultural management.
Related Results
Cytogenetics, conserved synteny and evolution of chicken fucosyltransferase genes compared to human
Cytogenetics, conserved synteny and evolution of chicken fucosyltransferase genes compared to human
Fucosyltransferases appeared early in evolution, since they are present from bacteria to primates and the genes are well conserved. The aim of this work was to study these genes in...
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Background. Benign prostatic hyperplasia (BPH) has recently been linked to diabetes mellitus and insulin resistance. This study aims to explore whether the use of either sodium-glu...
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis
IntroductionThis meta-analysis aims to evaluate the efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors [PD-(L)1 inhibitors] for muscle-invasive bladder carcinom...
Chemoinformatics Approaches to Virtual Screening
Chemoinformatics Approaches to Virtual Screening
Chemoinformatics is broadly a scientific discipline encompassing the design, creation, organization, management, retrieval, analysis, dissemination, visualization and use of chemic...
EFEKTIFITAS PELATIHAN LABORATORIUM VIRTUAL SEBAGAI MEDIA PEMBELAJARAN BAGI GURU KIMIA
EFEKTIFITAS PELATIHAN LABORATORIUM VIRTUAL SEBAGAI MEDIA PEMBELAJARAN BAGI GURU KIMIA
EFFECTIVITY OF VIRTUAL LABORATORY TRAINING AS A LEARNING MEDIA FOR CHEMISTRY TEACHERSAchmad Lutfi, SukarminUniversitas Negeri Surabaya, Indonesia achmadlutfi@unesa.ac.idAbstractThe...
Effects of Dolutegravir and Protease Inhibitors based Regimen on Renal and Liver Function Markers of HIV Patients Attending Daughters of Charity Hospital Abuja
Effects of Dolutegravir and Protease Inhibitors based Regimen on Renal and Liver Function Markers of HIV Patients Attending Daughters of Charity Hospital Abuja
Human immunodeficiency virus (HIV) is a serious public health that has been managed by different HAART regimen for people infected to live a healthier live and also reduce the risk...
IDENTIFICATION OF NEW CYCLOOXYGENASE-2 SELECTIVE INHIBITORS VIA VIRTUAL SCREENING AND COMPLEX-BASED PHARMACOPHORE MAPPING
IDENTIFICATION OF NEW CYCLOOXYGENASE-2 SELECTIVE INHIBITORS VIA VIRTUAL SCREENING AND COMPLEX-BASED PHARMACOPHORE MAPPING
Background: New and effective COX-2-targeted medications may cure cancer, inflammation, and other disorders.It’s difficult to produce druggable site inhibitors for target protein i...

